Dogs are naturally exposed to numerous pathogenic serogroups. Leptospirosis vaccines are claimed to afford a clinical protection restricted to the serogroups of which they are composed. Objectives: Dogs exhibiting liver and kidney injury were suspected of having leptospirosis. The purpose of this study was to compare the microscopic agglutination test (MAT) results in naive and vaccinated dogs experiencing leptospirosis outcomes. Only MAT-positive animals were included in the study. Methods: Over five years, 3 512 dogs were suspected of having leptospirosis. For each case, biochemical parameter results were recorded. Leptospirosis involvement was investigated by MAT performed against 6 major serogroups (Icterohaemorrhagiae, Canicola, Australis, Autumnalis, Grippotyphosa and Sejro€ e). MAT-positive results confirmed leptospirosis cases in 147 naïve dogs and in 580 fully vaccinated dogs.
Introduction
Acute leptospirosis with fatal outcome is commonly recorded in dogs, which are highly receptive to this type of infection [1] . More than 8 pathogenic serogroups have been detected worldwide in canines [2, 3, 4, 5] . The agglutinating antibodies raised against these pathogenic serogroups were shown by the serological microscopic agglutination test (MAT) from the tenth day after disease onset. MAT has been widely used to confirm leptospirosis cases [2, 6] , indicating the most infectious serogroups. Formerly, canine vaccination was performed worldwide by bivalent whole cell vaccines, including the two major serogroups, Icterohaemorrhagiae (IH) and Canicola (CAN). The bacterins trigger agglutinating antibodies, which afford clinical protection. However, this protection is believed to be restricted to the composing serogroups of the vaccine [3] . The vaccine strategy to extend the protection against other pathogenic serogroups without any safety impairment was to add the most relevant among the approximately 25 available pathogenic serogroups [7, 8, 9] to be closer to the epidemiological status [10] . The goal of this study was to estimate the clinical protection afforded by vaccination in the field.
To avoid misdiagnosis, this retrospective study took place exclusively when Icterohaemorrhagiae and Canicola bivalent vaccines were only sold in France and when the MAT was the single tool for confirming leptospirosis cases [2, 11, 12] . Onset of leptospirosis was clinically suspected in 3 512 pets either naive (nV) or vaccinated with these bacterins. Clinical, biological and epidemiological data were recorded, and MAT was performed with each of the sera withdrawn from leptospirosis suspected dogs.
The study was only focused on dogs suspected of having leptospirosis due to exhibiting acute hepatitis and/or nephritis. The first step was to determine the liver and kidney injury patterns of each of the 6 major serogroups based on the MAT results of unvaccinated dogs. Therefore, comparison of the cases recorded in vaccinates and naïve cases allowed a global estimation of the serological and clinical impacts triggered by the usual whole cell bacterins.
Materials and methods

Data collection
A form was distributed among veterinary practitioners to collect clinical data of pets suspected of having leptospirosis.
The template, necessary to confirm or reject a leptospirosis case by MAT results, was prepared by the laboratory:
Delay of sampling since the onset of the disease Delay of sampling since the last leptospirosis vaccination (primo vaccination or boost, without any record of the vaccine company).
Symptom criteria collection
Liver injury (L): results of APL, ALT and biliary acids, icterus.
Acute kidney injury (AKI): blood urea (BUN) and creatinine.
Gastroenteritis, vomiting.
Other symptoms relevant to leptospirosis, including bleeding, pulmonary distress or reproductive disorders.
Three grades of liver injury were defined by comparison with normal values (Table 1) [ 13, 14] . The third grade was estimated as severe liver injury (SL). Grades of acute kidney injury (AKI) were designated according to the International Renal Interest Society recommendations [15] . Grades III to V were representative of severe AKI (SK).
Symptoms were independently recorded for each dog. Therefore, each syndrome had to be independently studied.
MAT
As previously described [4, 5] , the dogs sampled in France showed MAT-positive results to 6 major serogroups, the bacterin serogroups (Icterohaemorrhagiae and Canicola), and Australis (AUS), Autumnalis (AUT), Grippotyphosa (GRIP) and Sejro€ e (SEJ). A panel of 16 serovars (reference strains and local isolates), routinely used for these 6 serogroups, were used in this study.
A titre of 1:40 was considered positive. Nevertheless, in vaccinated animals, Icterohaemorrhagiae and Canicola reciprocal titres from 40 to 320 were considered as post-vaccination titres. The prominent serogroup was designed by the serovar exhibiting the highest titre, regardless of the positive serovar.
Case definition
The completion of the data sheet was necessary for any case confirmation.
A leptospirosis case was first excluded if the data related to the 5 selected biochemical and epidemiological factors were not relevant to clinical leptospirosis, and in a second step if MAT results were negative. Confirmation was serologically assessed by positive MAT results according to the algorithm previously defined [16] , which, briefly, took into account: 
Statistical analysis
The data forms and MAT results were stored by Access 2000 software.
The results were treated by Pearson's chi-squared tests. Results were significant for P 0.05. Confidence intervals were expressed for P ¼ 0.05 (CI 95% ¼ x 1 -x 2 ).
Results
Canine population suspected of having leptospirosis
Over the 5 years of the study, canine sera of 3 512 clinically suspected dogs were sent to the laboratory for MAT confirmation. Only 997 dogs suspected of having 
MAT results
In MAT, a suspected dog belonging to the group of unvaccinated animals exhibited agglutinating antibodies to a mean of 2.36 different serogroups (347 MAT-positive results against the 6 most reactive serogroups). Sera samples provided by 580 vaccinates exhibited 1 506 positive results (mean ¼ 2.60). However, when positive results for Icterohaemorrhagiae and Canicola were retrieved because they could be attributed to the previous vaccination performed in these animals, this mean dropped to 1.09.
The seroprevalence of each serogroup was estimated by using the threshold dilution of 1:40, but has to be evaluated according to these numerous responses. In the group of unvaccinated dogs, the highest seroprevalence of 77.6% (CI 95% ¼ 70.9e84.3) was shown by Icterohaemorrhagiae ( Fig. 2 The natural incidence of each serogroup could be roughly estimated by the highest reciprocal titres (!320). The highest seroincidence (Fig. 2) 
Vaccinated dogs
In the group of vaccinated dogs, the Icterohaemorrhagiae and Canicola seroprevalences must be considered "apparent" prevalences as they included the serological consequences of previous vaccination. Similarly, incidence estimated by reciprocal high titres had to be studied separately from the other serogroups for Icterohaemorrhagiae and Canicola (!320), which could be related to the previous Leptospira vaccination.
Icterohaemorrhagiae and Canicola
High titres for Icterohaemorrhagiae and Canicola were found in 58.4% and 12.6% of the dogs, respectively. However, the titres against Icterohaemorrhagiae and Canicola decreased with the time elapsed since the last vaccination (Fig. 3) . They decreased from 60% for Icterohaemorrhagiae and 15% against Canicola when the previous vaccination was performed during the previous 6 months to 45 .6% and 7.4% in the group of 136 dogs whose vaccination was not valid (V-) (Fig. 3 ). This decrease of MAT results was significant for both Icterohaemorrhagiae and Canicola (P ¼ 0.040 and P ¼ 0.022) when the last vaccination was performed more than 1 year ago. Conversely to the low titres, high titres against the other serogroups could not have been elicited by a previous vaccination and therefore expressed the incidence. For Australis, high titres were shown in 17.9% of cases (CI 95% ¼ 15.1e20.7), followed by 11.2% for Sejro€ e (CI 95% ¼ 9.1e13.8) and Grippotyphosa and Autumnalis with 6.9% (CI 95% ¼ 4.8e8.4) and 6.9% (CI 95% ¼ 4.5e8.1), respectively (Fig. 4) . severe hepatitis cases, whereas high titres to Canicola were only related to 3 severe AKI cases. Whatever the other focused serogroup, high titres were mostly related to severe AKI cases. Other detected clinical aspects of leptospirosis were generally associated with one or two of these symptoms. The ratio of severe cases of liver injury and AKI was dependent from the serogroup (Fig. 5 ). All the serogroups showed a stronger renal effect, Sejro€ e excluded. Icterohaemorrhagiae-related renal cases of naïve dogs were significantly higher (P ¼ 0.0019) than cases for the other serogroups.
Clinical results
Among showed high Canicola titres. Icterohaemorrhagiae-related severe kidney damage was seen in 71 dogs (12.2%) and in 8 (1.4%) cases related to Canicola.
Discussion
Several limits of this study performed in privately owned pets exposed to field strains of pathogenic Leptospira species throughout France [17] depended of the selected criteria. Clinical picture was the first selection filter. The clinical recording of cases in vaccinates and naïve dogs was implemented by the same practitioner population. To minimise recording bias, this study only focused on the easy to quantify biochemical parameters of the well-known issues among various aspects of polysystemic leptospirosis [18, 19, 20, 21, 22] . The biochemical levels were used to define cases and to perform statistical analyses. As MAT is very specific [6] , sensitivity was improved by use of a low first sera dilution (1:20) . Therefore, the final reciprocal titre consistent with the clinical picture was 320 (fourth dilution) instead of the widely used threshold of 400 [9, 23] . An infectious strain usually belongs to a single serovar belonging itself to a single serogroup. However, a serum commonly shows crossreactivity for several serogroups. Therefore, MAT results are often considered as poor indicators of the serogroup to which belongs the infectious strain [24] , but the highest titre against a given serogroup is statistically correlated to the serogroup inducing the last infection of a naive dog [25] whatever the prominent serovar reacting in MAT within this serogroup. Morozetti Blancoa [26] showed 79% agreement between the serogroup predicted by MAT and the isolate identification. Therefore, the highest titre was considered consistent to the infectious serogroup and lower titres as cross-reactions.
Our purpose was to estimate the global protection elicited by bacterins in vaccinates exposed to the most pathogenic serogroups encountered in France highlighted by MAT results of sick unvaccinated pets (Fig. 2) . The MAT was performed and recorded in a single laboratory avoiding most laboratory bias [5, 16] .
Sera provided by unvaccinated dogs gave positive results to a mean of 2.36 different serogroups, highlighting the high level of cross-reactivity within the 6 field serogroups. As expected vaccinated dog samples exhibited a higher mean of seroreactive serogroups (2.60). New antibodies raised towards the infectious strain are added to the post-vaccine agglutinating antibodies (Icterohaemorrhagiae and Canicola).
They increased the cross-agglutinations [25] . In agreement with this hypothesis, if the Icterohaemorrhagiae and Canicola agglutinins were retrieved, cross-reactions dropped from 2.60 to 1.091 in the Vþ dogs compared to 2.36 to 1.28 in the nV dogs.
Icterohaemorrhagiae remained the major infectious serogroup as shown by the highest incidence in naïve dogs (44.2%), whereas Canicola appeared as the least infectious with 3.4%. Similar lower exposure (approximately minus 40%) was confirmed in vaccinates even if the previous vaccination allowed serological result increase (Icterohaemorrhagiae incidence 58% and Canicola 12%). These results are in accordance with previous data [3, 7, 27, 28, 29, 30] . The numerous animal species able to shed Icterohaemorrhagiae compared to the restricted Canicola maintenance hosts could be an explanation of such different exposures of dogs.
Protection triggered by bacterins is claimed to be serogroup-specific [3, 7, 8] . The major liver failure decreased from 57.8% in naive dogs to 46.5% in vaccinates and AKI from 51.7% to 21.6% (P ¼ 2.10 À5 ). Moreover, the severe form of AKI (all serogroups included) significantly dropped in vaccinates from 46.9 to 20.0% (P ¼ 6.10 À6 ). The specificity of that protection was questionable in naturally exposed vaccinates [31, 32] . It was very noticeable that the rate of upper grades of AKI related to Icterohaemorrhagiae and Canicola serogroups significantly decreased from 60% (39/ 65) in naïve dogs to 20.9% (71/339) for Icterohaemorrhagiae and from 60% (3/5) to 10.9% (8/73) for Canicola. MAT high titres were the combination of the previous vaccination and the last infection and show that field infections boost the previous antibodies while the newly infected animals were clinically protected. Therefore, the potential consequences of this vaccination has to be explored for the 4 other heterologous serogroups (Australis, Autumnalis, Grippotyphosa and Sejro€ e).
It was hypothesised that natural exposure of vaccinates could not be higher than that of naïve dogs. However, high titres against Autumnalis and Grippotyphosa increased in vaccinated dogs compared to naïve dogs (Fig. 4) . It has been suggested that both these serogroups serologically cross-react with Icterohaemorrhagiae and/or Canicola. In this case, similar antibody increase would be shown for high titres linked to severe liver or kidney damage. This was valuable for Autumnalis high titres, but not for Grippotyphosa (Fig. 5) . Therefore, it was hypothesised that the major liver or kidney troubles taken into account in this study were not the prominent clinical signs in these Grippotyphosa cases. These results are in accordance with the proper name given to this serogroup (flu-like and typhus), suggesting a particular clinical impact of serovars belonging to this serogroup [2, 33] .
Conversely, severe liver and kidney damage cases related to Australis and Sejro€ e high titres decreased (Fig. 5) . Therefore, it can be assumed that the former Icterohaemorrhagiae and Canicola vaccination afforded an unexpected clinical protection against the major liver and kidney failure of leptospirosis cases induced by at least the 3 heterologous serogroups, Australis, Grippotyphosa and Sejro€ e.
It is well known that the widely cross-agglutinating saprophytic L. biflexa is unable to afford any protection [3, 10, 34] , whereas cross-reactive in MAT, lipopolysaccharides (LPS) epitopes are unable to share this cross-protection, in accordance with the claimed specificity of the bacterins. Therefore, these results emphasise that the usual whole cell vaccines elicit a broader immune response [35] . Pathogenic Leptospira spp share many other common and specific antigens [36] , such as lipL32/Hap1
and other outer membrane proteins [37, 38, 39, 40, 41] . A new field infection of a vaccinate would boost his previously acquired immunity against LPS epitopes and simultaneously against some of the specific outer membrane proteins [42, 43, 44] . During the host invading process, non-LPS-specific immunity may be enhanced, affording an early significant but not fully achieved and short-term cross-protection [34, 42] . In the complement of the reference MAT, newly developed enzymelinked immunosorbent assays (ELISAs) using these various antigens for coating supported this immune response complexity [45, 46, 47] . In pets exposed to infectious field strains, specific LPS agglutinating antibodies are efficient but are only one of the factors affording the clinical protection against leptospirosis. The useful pattern of antigens to achieve a complete protection against pathogenic Leptospira spp remains to be identified [48] .
In conclusion, whole cell bacterins afford a significant protection against field strains belonging to homologous serogroups as well as heterologous pathogenic Leptospira spp regardless of their composition.
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